These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9243519)

  • 1. Neostriatal neurons of rats can be influenced by cholecystokinin-A receptor agonists.
    Davidowa H; Wetzel K; Henklein P
    Neuropeptides; 1997 Jun; 31(3):231-5. PubMed ID: 9243519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of cholecystokinin analogs in which the Asp-Phe-NH2 moiety has been replaced by a 3-amino-7-phenylheptanoic acid or a 3-amino-6-(phenyloxy)hexanoic acid.
    Amblard M; Rodriguez M; Lignon MF; Galas MC; Bernad N; Artis-Noël AM; Hauad L; Laur J; Califano JC; Aumelas A
    J Med Chem; 1993 Oct; 36(20):3021-8. PubMed ID: 7692048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological activities of pseudopeptide analogues of the C-terminal heptapeptide of cholecystokinin. On the importance of the peptide bonds.
    Rodriguez M; Lignon MF; Galas MC; Fulcrand P; Mendre C; Aumelas A; Laur J; Martinez J
    J Med Chem; 1987 Aug; 30(8):1366-73. PubMed ID: 2441054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The excitatory effect of cholecystokinin on rat neostriatal neurons: ionic and molecular mechanisms.
    Wu T; Wang HL
    Eur J Pharmacol; 1996 Jun; 307(2):125-32. PubMed ID: 8832213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cholecystokinin agonists on striatal neurons are reduced by acetylcholine.
    Davidowa H; Wetzel K; Vierig G
    Peptides; 1997; 18(4):541-5. PubMed ID: 9210173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of N- and C-terminal substituents on the CCK-B agonist-antagonist pharmacological profile of Boc-Trp-Phg-Asp-Nal-NH2 derivatives.
    Weng JH; Blommaert AG; Moizo L; Bado A; Ducos B; Böhme A; Garbay C; Roques BP
    Bioorg Med Chem; 1996 Apr; 4(4):563-73. PubMed ID: 8735845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based design of new constrained cyclic agonists of the cholecystokinin CCK-B receptor.
    Blommaert AG; Dhôtel H; Ducos B; Durieux C; Goudreau N; Bado A; Garbay C; Roques BP
    J Med Chem; 1997 Feb; 40(5):647-58. PubMed ID: 9057851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minor structural differences in Boc-CCK-4 derivatives dictate affinity and selectivity for CCK-A and CCK-B receptors.
    Shiosaki K; Lin CW; Kopecka H; Bianchi B; Miller T; Stashko M; Witte D
    J Med Chem; 1997 Mar; 40(7):1169-72. PubMed ID: 9089338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of growth of azaserine-induced putative preneoplastic lesions in rat pancreas is mediated specifically by way of cholecystokinin-A receptors.
    Povoski SP; Zhou W; Longnecker DS; Roebuck BD; Bell RH
    Cancer Res; 1993 Sep; 53(17):3925-9. PubMed ID: 8358719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCK-A receptor selective antagonists derived from the CCK-A receptor selective tetrapeptide agonist Boc-Trp-Lys(Tac)-Asp-MePhe-NH2 (A-71623).
    Sugg EE; Kimery MJ; Ding JM; Kenakin DC; Miller LJ; Queen KL; Rimele TJ
    J Med Chem; 1995 Jan; 38(1):207-11. PubMed ID: 7837233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and binding affinities of cyclic and related linear analogues of CCK8 selective for central receptors.
    Charpentier B; Dor A; Roy P; England P; Pham H; Durieux C; Roques BP
    J Med Chem; 1989 Jun; 32(6):1184-90. PubMed ID: 2724293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCK-B agonist or antagonist activities of structurally hindered and peptidase-resistant Boc-CCK4 derivatives.
    Corringer PJ; Weng JH; Ducos B; Durieux C; Boudeau P; Bohme A; Roques BP
    J Med Chem; 1993 Jan; 36(1):166-72. PubMed ID: 8421283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of in vivo pancreatic growth in the rat is mediated specifically by way of cholecystokinin-A receptors.
    Povoski SP; Zhou W; Longnecker DS; Jensen RT; Mantey SA; Bell RH
    Gastroenterology; 1994 Oct; 107(4):1135-46. PubMed ID: 7523219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholecystokinin excites neostriatal neurons in rats via CCKA or CCKB receptors.
    Davidowa H; Albrecht D; Gabriel HJ; Heublein S; Wetzel K
    Eur J Neurosci; 1995 Dec; 7(12):2364-9. PubMed ID: 8845940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiological studies with new CCK analogs: correlation with binding affinity on B-type receptors.
    Böhme GA; Durieux C; Stutzmann JM; Charpentier B; Roques BP; Blanchard JC
    Peptides; 1989; 10(2):407-14. PubMed ID: 2755879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCK-A-selective tetrapeptides containing lys(N epsilon)-amide residues: favorable in vivo and in vitro effects of N-methylation at the aspartyl residue.
    Bennett MJ; Nikkel AL; Bianchi BR; Miller TR; Bednarz L; Witte DG; Stashko M; Wang SS; Gore PA; Asin KE
    J Med Chem; 1994 May; 37(11):1569-71. PubMed ID: 8201591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactive effects of cholecystokinin-8S and various serotonin receptor agonists on the firing activity of neostriatal neuronesin rats.
    Wilms K; Vierig G; Davidowa H
    Neuropeptides; 2001; 35(5-6):257-70. PubMed ID: 12030810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of topographical constraints in receptor mapping: investigation of the topographical requirements of the tryptophan 30 residue for receptor binding of Asp-Tyr-D-Phe-Gly-Trp-(N-Me)Nle-Asp-Phe-NH2 (SNF 9007), a cholecystokinin (26-33) analogue that binds to both CCK-B and delta-opioid receptors.
    Boteju LW; Nikiforovich GV; Haskell-Luevano C; Fang SN; Zalewska T; Stropova D; Yamamura HI; Hruby VJ
    J Med Chem; 1996 Sep; 39(20):4120-4. PubMed ID: 8831778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid antagonist naloxone potentiates anxiogenic-like action of cholecystokinin agonists in elevated plus-maze.
    Kõks S; Soosaar A; Võikar V; Volke V; Ustav M; Männistö PT; Bourin M; Vasar E
    Neuropeptides; 1998 Jun; 32(3):235-40. PubMed ID: 10189057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical and initial clinical evaluation of 111In-labeled nonsulfated CCK8 analog: a peptide for CCK-B receptor-targeted scintigraphy and radionuclide therapy.
    de Jong M; Bakker WH; Bernard BF; Valkema R; Kwekkeboom DJ; Reubi JC; Srinivasan A; Schmidt M; Krenning EP
    J Nucl Med; 1999 Dec; 40(12):2081-7. PubMed ID: 10616889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.